Though the decidua serves a critical function in implantation, the hormonal regulated pathway in decidualization is still elusive. Here we describe in detail the regional distribution and the effects of progesterone receptors (PGR), estrogen receptors (ESR), and MAPK activation on decidualization. We showed an increase in PGR A, PGR B, ESR1, and phosphorylated MAPK3-1 proteins (p-MAPK3-1), but not in ESR2, in the decidual tissue up to Day 8 of pregnancy. PGR was predominantly found in the nuclei of mesometrial decidual cells and of undifferentiated stromal cells where it colocalizes with ESR2 and ESR1. In the antimesometrial decidua, all the receptors showed cytoplasmic localization. MAPK was activated exclusively in undifferentiated stromal cells of the junctional zone between the antimesometrial and mesometrial decidua and at the border of the antimesometrial decidua. Treatment with the progesterone antagonist onapristone and/or the estrogen antagonist faslodex reduced the extent of decidual tissue and downregulated the levels of PGR and ESR1. The expression level of ESR2 was affected only by the progesterone receptor antagonist, while neither the antiprogestin nor the antiestrogen significantly modified the p-MAPK3-1 level. The inhibition of MAPK3-1 phosphorylation by PD98059 impaired the extent of decidualization and the closure reaction of the implantation chamber, and significantly downregulated ESR1. These results confirm a role of both steroid receptors in the growth and differentiation of the different decidual regions and suggest a new function for p-MAPK3-1 in regulating expression levels of ESR1, thereby maintaining the proliferation capacity of stromal cells and limiting the differentiation process in specified regions of decidual tissues. decidua, ESR1, ESR2, estradiol/estradiol receptor, female reproductive tract, hormonal antagonist, kinases, PGR, p-MAPK, progesterone/progesterone receptor, rat
INTRODUCTION
Implantation requires profound changes in the uterus for successful progression and maintenance of pregnancy. One of the most important stromal reactions to implantation in rodents is the decidualization process, which is coordinated by two basic events: first, the priming effect of the steroid hormones estradiol and progesterone and, second, the signaling interaction with the implanting blastocyst [1, 2] . The importance of embryonic signaling for decidualization has been shown for leukemia inhibitory factor [3] activating the HBEGF [4] and PTGS2 (COX-2) pathway. The PTGS2-derived prostacyclin as well as interleukin 11 are key regulators for decidualization [5] [6] [7] . Proliferation of the endometrial stromal cells followed by differentiation into decidual cells is primarily governed by both progesterone and estradiol, at least in rodents [8, 9] . This complex tissue remodeling is thought to ensure proper maternal-fetal interactions and to guide trophoblast invasion and placental orientation.
Both cell physiological events-proliferation and differentiation-are mainly governed by progesterone, a fact that has been documented by using antiprogestins [10, 11] . Progesterone alone is able to induce uterine stromal proliferation before decidualization, and this effect is potentiated by estrogens [12] . Progesterone acts through its two receptor isoforms PGR A and PGR B, which are expressed from a single gene [13, 14] and have different responses to the ligand. Evidence that progesterone is crucial for decidualization come from PGR-deficient mice [15] . Selective ablation of PGR A and PGR B show a distinct contribution of these two isoforms in reproduction. PGR A deficiency results in ovarian and uterine hyperplasia leading to infertility, while PGR B accounts for the response of the mammary gland to progesterone. The different action of both isoforms is mediated by transactivation of distinct progesterone-dependent target genes [14, 16] .
The induction of progesterone receptors in the uterus seems to be mediated by estrogen [17, 18] . In addition, estrogens amplify stromal proliferation during the pre-and periimplantation phase in a progesterone-primed uterus [19] . Estrogen mediates its function through two nuclear estrogen receptors, ESR1 (ERa) and ESR2 (ERb), both of which exhibit a high affinity for their ligand but show differential expression pattern in tissues and cells [20] . It has been shown that besides the ESR1 protein, ESR2 is expressed in mouse as well as in rat decidual cells [21, 22] . ESR1 mRNA and protein are localized mesometrially on Days 6-8 of pregnancy in mice [21, 23] . The mouse uterus exhibits only a small amount of ESR2 during implantation whereas rats show a clear localization of ESR2 at the antimesometrial side of the decidua. Mice missing ESR1 are still able to decidualize [24, 25] , and depletion of ESR2 does not impair uterine morphology [26] . These studies suggest that neither ESR2 nor ESR1 is necessary for the decidualization process in mice. 1 Supported by the DAAD, Germany and SECYT, Argentina exchange program PROALAR; and by grants to P.S. from Agencia Nacional de Promoció n Científica y Tecnoló gica (PICT 5-34086) Argentina and Consejo Nacional de Investigaciones Científicas y Té cnicas (PIP 2005 (PIP -2006 Recently, in vitro studies by our group [27] found that induction of proliferation upon the addition of progestins requires both PGR and ESR2 in a stromal cell line of rat endometrium. However, both receptors need to interact in the cytoplasm for activation of the extracellular signal-regulated kinases 1 and 2 (MAPK3-1) and AKT signaling pathways. MAPK3 and MAPK1 are ubiquitous and multifunctional signaling proteins that are involved in most cellular responses to extracellular signals and function in many aspects of developmental biology [28, 29] , but there is little information about the signaling cascades that govern the decidualization process in rodent endometrium in this tightly controlled temporal and spatial manner. Morphologically, the decidualization process is a highly complex event reflecting probably different functions for the different decidual compartments. The process of decidualization is strongly regionalized with two main decidual cell populations: the antimesometrial part and the mesometrial part. Antimesometrial decidualization starts in stromal cells surrounding the implanting blastocyst, forming the primary decidual zone as a compact tissue with an epitheloid character that expands radially toward the muscle layers. The mesometrial part, which never turns to a very compact tissue, develops together with the placenta and forms the decidua basalis. The two parts are clearly separated by a junctional zone, the region of the closure reaction of the uterine lumen, which is composed of nondecidualized stromal cells and contains most of the vessels orientated toward the developing placenta [30] . The development of an extensive vascular network within this stromal/decidual tissue is crucial for the survival of the embryo before a functional placenta is developed [31, 32] . Another nondecidualized area is the region underneath the myometrium surrounding both decidual parts. The different distribution of the steroid receptors within those different parts of the decidual tissue and the undifferentiated stromal cells are a strong indication that signaling cascades of the differentiation process are complex and regionally diversified [21] . Our study defines progesterone and estrogen receptors-mediated regionalized decidualization processes and the role of p-MAPK3-1 (phosphorylated MAPK3-1 proteins) in the decidualization process in the different compartments.
MATERIALS AND METHODS

Cell Culture
T47D human breast cancer cells (ATCC Bioresource Center) were routinely grown in Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum (FBS), 2 mM l-glutamine, 100 U/ml penicillin, and 100 lg/ml streptomycin [33] . UIII rat normal uterine stromal cells (Dr. H. Cohen, Laboratorie de Physiologie-Pharmacodynamie, Villeurbanne, France) were maintained in M199 medium supplemented with 10% FBS, penicillin (100 U/ ml), and streptomycin (100 lg/ml) at 378C in humidified 95% air with 5% CO 2 [27] . The culture media were changed every 2 days.
Animal Care
Adult female Wistar rats (Schering, TZH) were housed under defined conditions with a temperature of 228C 6 18C, an atmospheric humidity of 55% 6 10%, and a 12L:12D cycle. They were fed standard pellet food and provided with water ad libitum. All the animal experiments were approved by the Institutional Animal Care Committees of the Instituto de Biologia y Medicina Experimental and the Universitaetsklinikum Duisburg-Essen.
Pregnancy
Mating was performed overnight with male animals, and the following morning the presence of cornificated cells and sperm was evaluated by vaginal smear. The day of sperm finding was designated as 0 day postcoitum (0 dpc). The 4-dpc pregnancies were confirmed by flushing the uterus and counting the number of blastocysts in each horn. The 6-and 8-dpc pregnancies were confirmed by the presence of implantation sites (IS).
Hormone Antagonists and MAPK Inhibitor Treatments
The antiprogestagen onapristone (ONA) (ZK 98299; Bayer Schering) and the antiestrogen faslodex (FAS) (ICI 182780; Tocris) were dissolved in ethanol and injected subcutaneously in sesame oil (200 ll/rat). Rats were injected daily with 1 mg ONA, 0.5 mg FAS, or 1 mg ONA þ 0.5 mg FAS at 6 and 7 dpc. One experimental group was injected i.p. with the MAPK phosphorylation inhibitor PD98059 (5 mg/rat/day; LC Laboratories) dissolved in 500 ll dimethyl sulfoxide (DMSO) [34] on Days 6 and 7 of pregnancy. Control animals were injected with 500 ll DMSO only. All the treated animals were killed on 8 dpc. In the PD98059 and DMSO experimental groups, the diameters of the implantation areas were measured (mm) with Image J 1.43 software (http:// rsbweb.nih.gov/ij/). Three animals were used for each experimental approach.
Tissue Collection
Rats were killed by cervical dislocation under isofluran anesthesia (DeltaSelect). The 4-dpc uterine horns were removed and cut into pieces, which were frozen in liquid nitrogen for subsequent Western blot analysis. Implantation sites from 6-and 8-dpc uterine horns were dissected. The portion of uterine horn between the implantation sites was designated as an interimplantation site (IIS). IS and IIS were frozen in liquid nitrogen for Western blot analysis or fixed in 4% formalin for morphologic and immunohistochemistry analysis.
Western Blot Analysis
Protein extracts were obtained from tissue samples by homogenization (Polytron PT-MR 300; Brinkmann Instruments) in 50 mM Tris HCl, 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, 1 mM ethylenediaminetetraacetic acid [EDTA], and 0.1% SDS supplemented with EDTA-free complete protease inhibitor cocktail and PhosSTOP phosphatase inhibitor cocktail (Roche). The protein concentration was determined by Bradford protein assay kit (Bio-Rad Laboratories). SDS-PAGE and immunoblot analysis were performed to detect progesterone receptor (PGR), estradiol receptor beta (ESR2), estradiol receptor alpha (ESR1), beta-actin (ACTB), GAPDH, p-MAPK3-1, and MAPK1. The following antibodies were used: rabbit polyclonal H190 anti-hPGR (1:1000; Santa Cruz Biotechnology Inc.); mouse monoclonal anti-hESR2 clone PPG5/10 (1:750; DAKO Inc.); rabbit polyclonal MC20 anti-mESR1 (1:2000; Santa Cruz Biotechnology Inc.); mouse monoclonal anti-hb-actin (1:1000; Sigma-Aldrich Co.); rabbit monoclonal 14C10 anti-hGAPDH (1:3000; Cell Signaling Technology); mouse monoclonal E10 against hMAPK3-1 (hERK1/2) phosphorylated at Thr202/Tyr204 (1:2000; Cell Signaling Technology); and rabbit polyclonal C14 anti-rMAPK1 (1:1000; Santa Cruz Biotechnology Inc.). A minimum of three blots from different rats were performed, and the band intensities were measured with ImageQuant 3.3 program (Amersham Pharmacia Biotech).
Histology
Implantation sites were fixed in 4% formalin, dehydrated in a graded series of alcohol, and embedded in paraffin. Cross-serial sections of 7-10 lm were deparaffinized, rehydrated in a graded series of alcohol, and stained with haematoxylin-eosin. Photographs were taken with an Axiophot microscope (Zeiss). The area of the different regions within the implantation sites were quantified with Image J 1.43 software (http://rsbweb.nih.gov/ij/) and delimited as shown in Supplemental Figure S1 (available online at www.biolreprod.org). The area of the whole implantation site was designated as 100%, and the contribution of the different tissue regions were calculated relative to the entire IS.
Immunohistochemistry
For immunostaining, paraffin sections (7-10 lm) were deparaffinized and rehydrated in a graded series of alcohols. After rinsing with phosphate-buffered saline (PBS; 1.3 mM NaH 2 PO 4 ÁH 2 O, 9.7 mM Na 2 HPO 4 , 145.4 mM NaCl; pH 7.4) for 5 min, the endogenous peroxidase was blocked and the sections were incubated with 0.5% bovine serum albumin (Sigma-Aldrich). The sections were incubated overnight at 48C with the primary antibodies, rinsed in PBS (33 for 5 min), incubated with a secondary biotinylated antibody (30 min at room temperature), and then with streptavidin-peroxidase complex (Millipore) for 30 min. Staining was visualized with 3,3-diaminobenzidine (DAKO Inc.). The following antibodies were used: rabbit polyclonal C-20 anti hPGR (Santa Cruz 1064 VALLEJO ET AL.
Biotechnology, Inc.); rabbit polyclonal H-150 anti-hESR2 (Santa Cruz Biotechnology, Inc.); rabbit polyclonal MC-20 anti-mESR1 (Santa Cruz Biotechnology, Inc.); rabbit monoclonal D13.14.4E against hMAPK3-1 (ERK1/2) phosphorylated at Thr202/Tyr204 (Cell Signaling Technology); rabbit polyclonal C14 anti-rMAPK1 (Santa Cruz Biotechnology, Inc.); and polyclonal goat anti-rabbit immunoglobulins/biotinylated (DAKO Inc.). Controls were performed by omitting the primary antibody.
Statistical Analysis
Analysis of variance was used for statistical testing; the Tukey multiple comparison test was used in Figures 1 and 3 ; the Dunnet comparison test was used in Figure 2 ; and a Student t-test was performed to compare steroids receptor expression in Figure 9 . Differences were considered significant if P , 0.05. Statistical analysis was carried out with GraphPad Prim 4.0 (GraphPad Software Inc.).
RESULTS
PGR, ESR, and p-MAPK3-1 Expression Levels Are Associated with Decidualization
The aim of this project was to study the role of PGR and ESR in the activation of MAPK3-1 during decidualization in the different decidual compartments. Western blots from uteri of 4-, 6-, and 8-dpc pregnant rats showed that both isoforms of PGR increased from 6 to 8 dpc, but with a stronger upregulation of PGR A compared to PGR B (Fig. 1A) . While ESR1 protein expression was increased at 6 and 8 dpc, ESR2 protein levels were not modified during early pregnancy (Fig.  1A) . Western blots for the activated isoform of MAPK revealed that p-MAPK3-1 levels increased up to 8 dpc (Fig. 1A) .
The decidualization process starts in response to the implanting embryo. In order to test whether the increase in PGR, ESR2, ESR1, and p-MAPK3-1 expression was dependent on the decidualization process, we compared their expression levels in IS with IIS from 6-and 8-dpc pregnant rats. We observed significantly higher levels of PGR A, PGR B, ESR1, and p-MAPK3-1 in the IS compared to the IIS from 6 and 8 dpc, while there were no differences in ESR2 (Fig. 1B) . The significant increase in PGR, ESR1, and p-MAPK3-1 protein expression in 8 dpc compared to 6 dpc in IS samples was not observed in the endometrium of the IIS. These results suggest that MAPK3-1 activation and elevation of PGR and ESR1 levels, but not ESR2 levels, are related to the decidualization process. We then focused on the hormonal influence on the decidualization process at 8 dpc because of the high expression levels of steroid hormone receptors and activated MAPK3-1 in this phase.
Effects of Estrogen and Progesterone Receptor Action on the Decidualization Process, Expression of Steroid Receptors, and p-MAPK3-1
Morphological changes in the decidualization process. In order to study the role of PGR, ESR, and PGR-ESR interaction on MAPK activation for decidualization, we treated pregnant rats at Day 6 and 7 with the PGR antagonist ONA and/or the ESR antagonist FAS. Morphology of implantation sites was analyzed at 8 dpc.
Animals treated with ONA revealed evident changes in the extension of the decidua in the implantation chamber compared to untreated control animals (Fig. 2) , revealing a constriction and an elongation of the decidua in the antimesometrial part. Interestingly, inner and outer myometrial layers were increased but only in the areas in contact with antimesometrial decidua. The mesometrial decidua appeared less differentiated and contained an enlarged junctional area and an undifferentiated zone underlying the myometrium (Fig. 2) . FAS-treated animals showed a reduced decidualization resulting in smaller implantion chambers, whereas regionalization and morphological appearance of the decidual regions were not severely changed compared to controls (Fig. 2) .
Animals treated with a combination of both antagonists presented a strong reduction in size of implantation sites due to a reduced extent of decidualization (Fig. 2) . Morphology of the decidua resembled more closely the phenotype of animals treated with ONA alone, revealing a similar decidua formation at the antimesometrial pole. However, the mesometrial decidua and the junctional area had practically disappeared.
Steroid receptor and p-MAPK3-1 protein levels. In the same experimental approach, the effect of ONA and/or FAS on PGR, ESR1, ESR2, and p-MAPK3-1 protein expression in the implantation sites was analyzed on 8 dpc (Fig. 3) . The levels of both PGR A and PGR B were strongly reduced by ONA, FAS, and ONAþFAS. Downregulation of ESR2 was obvious upon ONA and ONAþFAS treatment but not after treatment with FAS alone. ESR1 showed a significant downregulation upon ONA and upon FAS and a further decrease after treatment with both antagonists combined. Thus, estrogen as well as progesterone antagonists, alone and in combination, decreased PGR. A synergistic effect of estrogen and progesterone antagonists was only seen on ESR1 downregulation whereas ESR2 expression seemed to be more sensitive to ONA, which diminishes progesterone action on its receptor. Activated MAPK3-1 levels were not significantly modified by the different antagonist treatments.
Effect of Estrogen and Progesterone Receptor Action on PGR, ESR2, ESR1, and p-MAPK3-1 Expression Pattern
Next we investigated if the localization of PGR, ESR2, ESR1, and p-MAPK3-1 protein expression was modified by PGR and ESR antagonist treatments.
PGR immunohistochemistry. In control animals, PGR was expressed in decidualized and nondecidualized stroma cells of the entire implantation chamber (mesometrial decidua, antimesometrial decidua, under the myometrium, and the junctional zone) with an enhanced labeling in the antimesometrial decidual region (Fig. 4) . The receptor showed a nuclear localization in cells of the undifferentiated as well as of the mesometrial decidual regions but was restricted to the cytoplasm of antimesometrial decidual cells (Fig. 4, insets) .
ONA treatment resulted in a strong downregulation of PGRpositive signals in all regions of the decidual tissue (Fig. 4) , which confirmed the data from the Western blots. Similarly, FAS treatment resulted in a decrease in staining and revealed a more scattered distribution of PGR expression, predominantly in the mesometrial area (Fig. 4) . Treatment with both antagonists, ONA and FAS, showed a similarly reduced immunolabeling of progesterone receptors. However, a spotlike enhancement was observed in the mesometrial region (Fig.  4) . Interestingly, the subcellular localization of the receptor, which was nuclear in the undifferentiated and mesometrial zones and cytoplasmic in the antimesometrial zone, was unaffected by the antagonist treatments (Fig. 4, insets) .
ESR2 immunohistochemistry. A strong ESR2 staining was localized predominantly in the antimesometrial decidua of control animals at 8 dpc (Fig. 5 ). As seen with PGR, ESR2 showed a nuclear localization in the cells of the undifferentiated zone and the mesometrial decidua and a shift to the cytoplasm in the antimesometrial decidua cells (Fig. 5, insets) .
ONA or FAS treatment, alone or in combination, affected neither the localization nor the intensity of the ESR2 signal A) The kinetics of PGR, ESR2, ESR1, and p-MAPK3-1 protein expression during early decidualization. Western blots from 4, 6, and 8 days postcoitum (dpc) extracts were analyzed with antibodies as described in Materials and Methods. Samples from 6 and 8 dpc correspond to implantation sites (IS). PGR A, PGR B, ESR2, and ESR1 arbitrary units (AU) relative to ACTB AU and p-MAPK3-1 relative to MAPK1 AU for each stage of pregnancy were divided by the 4-dpc corresponding value. The arbitrary units of p-MAPK3 and p-MAPK1 were combined and divided by the corresponding MAPK1 AU. Data represent average 6 SEM from three animals for 4-, 6-, and 8-dpc pregnancies; the figure also shows a representative Western blot containing one sample for each stage of pregnancy. T47D, human mammary tumor cell line; Ov, rat ovary; UIII, cells from UIII rat uterine stromal cell line treated with epithelial growth factor; Ut, uterus. B) Association between PGR, ESR2, ESR1, and p-MAPK3-1 expression and decidualization. Western blots from 6-and 8-dpc IS and interimplantation sites (IIS) extracts were analyzed with the antibodies as described in Materials and Methods. Densitometric analysis was performed as in (A). *P , 0.05; **P , 0.01.
FIG. 2. Morphological effect of the inhibition of ESR and/or PGR signaling in the decidualization process. Top panel)
Morphology of 8-dpc implantation sites from untreated or treated (ONA, FAS, ONAþFAS) pregnant rats was analyzed in paraffin sections stained with haematoxylin-eosin. AM, antimesometrial decidua; M, mesometrial decidua; US, undifferentiated stroma; J, junctional zone between the AM and the M zones; UM, under myometrium; Myo, myometrium. Bar ¼ 1000 lm. Bottom panel) Quantitative analysis. The table shows the percentage of tissue areas corresponding to the different regions within the implantation sites. The area of each region relative to the corresponding whole implantation site area, designated as 100%, was calculated as described in Materials and Methods. Data represent average 6 SEM from four to six implantation sites from three animals for each treatment group. *P , 0.05, **P , 0.01 vs. the untreated 8-dpc corresponding region.
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VALLEJO ET AL. (Fig. 5) . In addition, the intracellular localization was unaffected by the antagonist treatments (Fig. 5, insets) .
ESR1 immunohistochemistry. Immunolocalization revealed that ESR1 was present in the entire decidua but, like PGR and ESR2, exhibited different subcellular localization in the different decidual compartments. ESR1 nuclear staining was strong in the mesometrial and junctional area and in some stromal cells underneath the myometrium. Antimesometrial ESR1 was present in the nuclei as well as cytoplasm of differentiated decidual cells located in the border of the myometrium and in the entire antimesometrial decidua (Fig. 6) .
ONA as well as FAS treatment resulted in a reduction of ESR1-positive signals in all the regions of the decidual tissue, and the ESR1-positive signals were even more downregulated by the combined ONA and FAS treatment (Fig. 6) , confirming the results of the Western blot analysis (Fig. 3) . The subcellular location of this steroid receptor with a nuclear staining in the mesometrial decidua, in the undifferentiated stromal cells of the junctional area, and underneath the myometrium, and a cytoplasmic staining in the antimesometrial region was not affected by antagonist treatment (Fig. 6, insets) .
Phosphorylated MAPK3-1 immunohistochemistry. The localization of p-MAPK3-1 in 8-dpc IS was restricted to the decidual cells at the lateral border of the antimesometrial decidua and some scattered cells in the primary decidual zone (Fig. 7) . Most of the expression was found in the undifferentiated cells of the junctional area, whereas the undifferentiated cells underneath the myometrium were not stained. The cellular localization was predominantly nuclear in all the cell types (Fig. 7, insets) .
The pattern of p-MAPK3-1 immunostaining in animals treated with ONA was similar to controls but the expression in the junctional zone was reduced. The antimesometrial and the mesometrial decidua revealed less p-MAPK3-1 labeling. Interestingly, p-MAPK3-1 expressing cells were reduced to a band separating the differentiated decidua from the stromal cells underneath the myometrium (Fig. 7) . FAS treatment reduced p-MAPK3-1 in the mesometrial decidua, but p-MAPK3-1 was strongly expressed in the extended junctional area. The distribution pattern of p-MAPK3-1 after treatment with ONA þFAS resembled the control but with an extended area in the junctional zone (Fig. 7) . In contrast, MAPK1 was homogeneously distributed throughout the decidual tissue and did not change upon treatment with the different antagonists (data not shown).
Effects of Inhibition of MAPK Phosphorylation on Decidualization and Steroid Receptor Expression
In order to evaluate the role for MAPK3-1 in the decidualization process, the MAP2K1 (MEK1) inhibitor PD98059 was injected on 6 and 7 dpc, resulting in a significant decrease in size of the IS (Fig. 8A ) compared to the vehicle control. Histology revealed a reduction of the decidual tissue in both the antimesometrial and mesometrial regions (Fig. 8B) . As evidenced by serial sections through the implantation chambers, the junctional zone after PD98059 treatment was more pronounced and showed, in contrast to the controls, a completed closure reaction (Fig. 8B) .
Western blot analysis of steroid receptors PGR, ESR1 and ESR2 in decidual tissues of MAP2K1 inhibitor-treated animals revealed a significant downregulation of ESR1 but not ESR2; in addition, both isoforms of PGR were diminished (Fig. 9) . 
Western blots from 8-dpc implantation sites from untreated or treated (ONA, FAS, ONAþFAS) pregnant rat uterine extracts were analyzed with antibodies as described in Materials and Methods. PGR A, PGR B, ESR2, and ESR1 arbitrary units (AU) relative to GAPDH AU and p-MAPK3-1 relative to MAPK1 AU for each treatment group were divided by the untreated 8-dpc control values. Densitometric analysis for p-MAPK3-1 was carried out as described in Figure 1 . The figure shows data representing average 6 SEM from three animals for each treatment group. A representative Western blot containing one sample of 8-dpc untreated and ONA, FAS, and ONA þ FAS treated animals are shown. *P , 0.05, **P , 0.01 vs. untreated 8-dpc IS.
ACTIVATED MAPK DURING IN VIVO DECIDUALIZATION
DISCUSSION
The interactions between ESR isoforms and PGR leading to signaling cascades that induce and regulate the decidualization process during pregnancy is not yet understood. Subsequent to our former findings on signaling in decidua and uterine stromal cell lines regulated by progesterone and/or estrogen [27, 30] , we explored here the role of steroid hormones and their receptors as well as the activation of MAPK3-1 in regulating the regionalized decidualization process in vivo.
While the regional and cellular distribution of PGR, ESR1, and ESR2 in the decidua did not change upon treatment with PLATE I. Figures 4, 5, 6 , and 7. 
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progesterone and estradiol antagonists, the levels of these proteins decreased to different extents in the decidual regions as a result of the estrogen and progesterone antagonist treatments. The downregulation of the receptor levels leading to a decrease in the ligand action was associated with the extent and shape of the decidua but not with regionalization and differentiation of the decidua. This fact points to a major role of both ligands in proliferation but not in differentiation. Our findings in the rat were similar to those of Tan et al. [21] who found an elevation of PGR and a steady state level of ESR2 in the decidua of mice at 8 dpc; however, the downregulation of ESR1 was not observed in the rat. This difference could be due to species differences in the time course of the decidualization processes.
Tessier et al. [22] were the first to demonstrate the presence of ESR2 in rat decidua during pseudopregnancy whereas in mice only low expression of ESR2 has been reported [21] . Human endometrial stromal cells reveal ESR2 throughout the cycle in all the endometrial compartments but mainly in the decidualized stromal cells surrounding the vessels [35] , pointing to a crucial role for ESR2 in the decidualization process in humans.
Cellular Receptor Distribution
Our most remarkable finding was that on 8 dpc the antimesometrial decidua revealed both isoforms of the ESR and the PGR receptor in the cytosol whereas ESR and PGR were located in the nuclei in the mesometrial decidual cells. The shift of PGR and ESR from the nucleus to the cytosol in antimesometrial decidua seems to correlate with advanced differentiation of decidual cells. The undifferentiated cells of the stromal zones in the implantation chamber, junctional zone between the antimesometrial and the mesometrial zones, and under the myometrium areas revealed ESR1, ESR2, and PGR, in the nucleus, which indicates a close interaction of the receptors. There are two possible interactions of hormone receptors according to their localization: at the nuclear level, probably via DNA target genes, and at cytoplasmic level where they interact with cytoplasmic kinases. Our former investigations showed that the ESR and PGR can interact with one another to activate MAPK and AKT in the cytoplasm and support proliferation [27, 33] , and it has been shown that activation of signaling cascades in the cytoplasm is essential for chromatin remodeling and transcriptional activation of a subset of steroid hormone target genes [36] . Our results support the idea that the nondecidualized cells that exclusively reveal activated MAPK connect the pathways of the steroid hormone receptors for regulating proliferation and differentiation during the decidualization process.
Blocking of Hormonal Receptor Actions and Functional Consequences
Blocking the steroid hormone receptors starting on Day 6 of pregnancy leads to reduced decidualization, revealing that both PGR and ESR have an effect on stromal cell proliferation even when they are applied after 6 days of pregnancy. Inhibiting PGR or ESR activity revealed that the two decidual compartments are differently regulated by the steroid hormones although the subcellular localization of ESR and PGR receptors in the different decidual compartments is not affected. Loss of PGR action by applying ONA does not obviously affect the antimesometrial decidual differentiation process. The decidual shape as well as the morphology of the individual cells is sustained. Because the cytosolic PGR seems no longer active in this compartment, the antimesometrial decidual differentiation program appears to be already established at 6 dpc. Because the mesometrial decidua is less differentiated and is continuously connected to the intermediated and undifferentiated zone, this decidual region seems to be still under the control of PGR. Because Pgr A knockout mice reveal an impaired decidualization process upon stimulation [14, 15] whereas Pgr B knockout mice have normal implantation [16] , it is more likely that PGR A drives the decidualization process. This corroborates our findings that PGR A levels increase more than PGR B during the decidualization process. FIG. 8 . Morphological effects of inhibition of MAPK3-1 phosphorylation on decidualization. Pregnant rats were injected i.p. with the MAP2K1 inhibitor PD98059 or the vehicle DMSO at 6 and 7 dpc. A) Macroscopic analysis of implantation chambers on 8 dpc in uteri of DMSO-and PD98059-treated rats. Bar ¼ 5 mm. Size of implantation sites were quantified as described in Materials and Methods. *P , 0.05. B) Histomorphology of 8-dpc implantation sites from DMSO-or PD98059-treated pregnant rats was analyzed in paraffin sections stained with hematoxylin-eosin. Bar ¼ 350 lm.
ACTIVATED MAPK DURING IN VIVO DECIDUALIZATION
Reducing ESR1 action by FAS treatment does not obviously affect the differentiation pattern of the decidua but seems to have an effect on its extension. These findings support the former observation that the proliferation of the stromal cells prior to differentiation is governed by estrogen [8] .
Tessier et al. [22] investigated ESR1 and ESR2 regulation by steroid hormones and prolactin using primary cultures from deciduomata and a decidual cell line. They found a downregulation of ESR1 that was dependent on progesterone, which is confirmed in our ONA experiments, however, only for the antimesometrial decidua. Furthermore, they gave evidence that ESR2 mediates estrogen-induced upregulation of the progesterone receptor in the decidua. In our experiments, blocking estrogen receptors did not change the amount of PGR in the mesometrial decidua but severely decreased PGR while maintaining ESR2 at the antimesometrial side. Taking into consideration that uterine decidual response is not impaired in ESR1-deficient mice [37] , ESR2 together with PGR appear to drive the decidualization process.
Phosphorylated MAPK3-1 Maintains the Extent of Decidua and Limits Decidualization in Specified Regions
A remarkable fact is that MAPK is predominantly activated in the junctional area between the mesometrial and antimesometrial decidua and limits the outer part of the antimesometrial decidua. The inhibition of phosphorylation of MAPK3-1 resulted in impairment of antimesometrial and mesometrial decidua development, showing a positive role in growth of decidual tissue for MAPK3-1.
Previous results from our laboratory showed that progestindependent proliferation is mediated by MAPK3-1 activation through a PGR-ESR2 preformed complex in the uterine stromal cell line UIII [27] . The junctional zone, which represents a specialized area contributing to the closure reaction and separation of the two decidual parts, does not undergo decidual differentiation despite expressing all the steroid receptors. The reason could be that this area is a leading scaffold structure for developing endometrial vessels supporting the growing embryo [32] , and a compact decidual tissue would impair angiogenesis. This hypothesis is supported by the colocalization with NOS2 in the endothelial cells of decidual vessels in this junctional zone and the pregnancy loss after inhibition of NOS2 [30] . Treatment with the MAP2K1 phosphorylation inhibitor during decidualization resulted in reduced mesometrial decidualization and an enhanced differentiated junctional zone. The decidual phenotype suggests that impairment of the MAPK signaling pathway leads to an imbalance in proliferation of stromal cells in favor of differentiation into decidual cells, predominantly in the junctional zone. Further investigations have to clarify if angiogenesis in the junctional zone is impaired and has an impact on embryonic survival. Artificial decidualization seems not to be affected by MAPK inhibitors as shown by Scherle et al. [38] . However, they only used an initial treatment at the start of the deciduogenic stimulus, and an organization into different decidual compartments along with the presence of a junctional zone is absent in deciduomata.
Most obvious was the downregulation of the steroid receptors, predominantly ESR1, by inhibition of MAPK3-1 phosphorylation. Thus, we cannot discriminate between a direct action of the MAPK pathway on decidualization and an indirect one by downregulating the ESR and PGR receptors. It is well-known that MAPK can act via ESR1 phosphorylation [39, 40] , and in breast cancer cells, activation of MAPK3-1 is able to regulate ESR1 expression levels but in an opposite way, that is, specific inhibition of MAPK3-1 result in an increase of ESR1 [41] . Our results suggest that the activation of MAPK3-1 in decidualization is probably necessary to stabilize the presence of ESR1 and its transcriptional activity via phosphorylation to promote proliferation and retarding or limiting differentiation of stromal cells into decidual cells during periimplantation.
